Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

ClinicalTrials.gov ID: NCT00098774

Public ClinicalTrials.gov record NCT00098774. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Intensive Chemotherapy And Immunotherapy In Patients With Newly Diagnosed Primary CNS Lymphoma

Study identification

NCT ID
NCT00098774
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Alliance for Clinical Trials in Oncology
Other
Enrollment
47 participants

Conditions and interventions

Conditions

Interventions

  • cytarabine Drug
  • etoposide Drug
  • filgrastim Biological
  • leucovorin calcium Drug
  • methotrexate Drug
  • rituximab Biological
  • temozolomide Drug

Drug · Biological

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2004
Primary completion
Dec 31, 2009
Completion
Aug 31, 2014
Last update posted
Jul 5, 2016

2004 – 2014

United States locations

U.S. sites
30
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94115
Tunnell Cancer Center at Beebe Medical Center Lewes Delaware 19958
CCOP - Christiana Care Health Services Newark Delaware 19713
University of Chicago Cancer Research Center Chicago Illinois 60637-1470
Fort Wayne Medical Oncology and Hematology Fort Wayne Indiana 46845
Hematology Oncology Associates of the Quad Cities Bettendorf Iowa 52722
Menorah Medical Center Overland Park Kansas 66209
Saint Luke's Hospital - South Overland Park Kansas 66213
Shawnee Mission Medical Center Shawnee Mission Kansas 66204
Union Hospital Cancer Program at Union Hospital Elkton MD Maryland 21921
Masonic Cancer Center at University of Minnesota Minneapolis Minnesota 55455
Truman Medical Center - Hospital Hill Kansas City Missouri 64108
Saint Luke's Cancer Institute at Saint Luke's Hospital Kansas City Missouri 64111
St. Joseph Medical Center Kansas City Missouri 64114
North Kansas City Hospital Kansas City Missouri 64116
Parvin Radiation Oncology Kansas City Missouri 64116
CCOP - Kansas City Kansas City Missouri 64131
Research Medical Center Kansas City Missouri 64132
Saint Luke's East - Lee's Summit Lee's Summit Missouri 64086
Liberty Hospital Liberty Missouri 64068
Heartland Regional Medical Center Saint Joseph Missouri 64506
Cancer Institute of New Jersey at Cooper - Voorhees Voorhees Township New Jersey 08043
Stony Brook University Cancer Center Stony Brook New York 11794-9446
SUNY Upstate Medical University Hospital Syracuse New York 13210
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus Ohio 43210-1240
Rhode Island Hospital Comprehensive Cancer Center Providence Rhode Island 02903
Miriam Hospital Providence Rhode Island 02906
Mountainview Medical Berlin Corners Vermont 05602
Fletcher Allen Health Care - University Health Center Campus Burlington Vermont 05401
Danville Regional Medical Center Danville Virginia 24541

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00098774, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 5, 2016 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00098774 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →